Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Morari Medical
Minnesota, United States
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Morari Medical has developed a transdermal neuromodulation-based wearable device (the MOR patch) to delay ejaculation for men with premature ejaculation. The product recently received FDA clearance and uses external neuromodulation to inhibit penile nerves and delay ejaculation. Published clinical results are limited; commercialization has just begun[1][2][4].
- Therapeutic areas
- Men's Health
- Modalities
- DeviceWearable deviceNeuromodulation
- Industry
- Therapeutic Medical Devices
02
Partnerships
gBETA Medtech Accelerator (with support from Boston Scientific, Mayo Clinic, and University of Minnesota)
Beyond the preview
Go deeper on Morari Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Morari Medical.